TrademarkDir
ADMIRE
DEAD

Serial Number

98066290

Owner

ABBVIE INC.

Attorney

Cheryl A. Withycombe

First Use Date

Jan 31, 2023

Filing Date

Jun 30, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ADMIRE Trademark

Serial Number: 98066290

ADMIRE is a trademark filed by ABBVIE INC. on June 30, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ABBVIE INC. (311 trademarks)

1 N. WAUKEGAN ROAD
NORTH CHICAGO, IL 60064

Entity Type: 03

Trademark Details

Filing Date

June 30, 2023

Registration Date

Not Registered

First Use Anywhere

January 31, 2023

First Use in Commerce

January 31, 2023

Published for Opposition

November 14, 2023

Goods & Services

providing information about medical clinical trials, namely, information in the field of improving diversity and inclusion in clinical research studies and clinical trials.

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 8, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 8, 2025 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 22, 2025 GNFN
FINAL REFUSAL E-MAILED
Apr 22, 2025 GNFR
SU - FINAL REFUSAL - WRITTEN
Apr 22, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2025 CRFA
ASSIGNED TO LIE
Apr 4, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 18, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 18, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 19, 2024 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 16, 2024 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Sep 16, 2024 SUPC
SOU EXTENSION 1 GRANTED
Sep 16, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 16, 2024 AITU
USE AMENDMENT FILED
Jul 14, 2024 IUAF
SOU EXTENSION 1 FILED
Jul 14, 2024 EXT1
TEAS STATEMENT OF USE RECEIVED
Jul 14, 2024 EISU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jul 14, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Jul 14, 2024 NREV
PETITION TO REVIVE-GRANTED
Jul 14, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 14, 2024 PROA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 9, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 9, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 9, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 9, 2023 CNEA
ASSIGNED TO EXAMINER
Oct 5, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 2, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2023 NWOS
NEW APPLICATION ENTERED
Jul 4, 2023 NWAP

Related Trademarks

More from this Owner

ABBVIE MEDICAL INSTITUTE

ABBVIE MEDICAL INSTITUTE

ABBVIE MEDICAL INSTITUTE logo

ABBVIE MEDICAL INSTITUTE

ABBVIE MEDICAL INSTITUTE

ABBVIE MEDICAL INSTITUTE

ABBVIE MEDICAL INSTITUTE logo

ABBVIE MEDICAL INSTITUTE

TYLISCO

TYLISCO

TYLISCO

TYLISCO